Pattern associated leukemia immunophenotypes and measurable disease detection in acute myeloid leukemia or myelodysplastic syndrome with mutated NPM1 - Zhou - 2019 - Cytometry Part B: Clinical Cytometry - Wiley Online Library
PROFILE OF CD150 EXPRESSION IN BONE MARROW CELLS OF PATIENTS WITH ACUTE MYELOID LEUKEMIA | Experimental oncology
Research | Majeti Lab | Stanford Medicine
CD33-directed therapy: Current and future perspectives on targeted therapy in acute myeloid leukaemia (AML)
IJMS | Free Full-Text | Flow Cytometric Identification of Hematopoietic and Leukemic Blast Cells for Tailored Clinical Follow-Up of Acute Myeloid Leukemia
Primary AML cells are killed by CD123-ENG T cells in vitro. (a) FACS... | Download Scientific Diagram
![PDF] High CD33 expression levels in acute myeloid leukemia cells carrying the nucleophosmin (NPM1) mutation | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0018cddf554044500f996f0e3a3724dd0a5a08be/3-Figure1-1.png "PDF] High CD33 expression levels in acute myeloid leukemia cells carrying the nucleophosmin (NPM1) mutation | Semantic Scholar")
PDF] High CD33 expression levels in acute myeloid leukemia cells carrying the nucleophosmin (NPM1) mutation | Semantic Scholar
Cancers | Free Full-Text | Redirecting the Immune Microenvironment in Acute Myeloid Leukemia
Frontiers | Current Advances in Immunotherapy for Acute Leukemia: An Overview of Antibody, Chimeric Antigen Receptor, Immune Checkpoint, and Natural Killer
Leukemic stem cell signatures in Acute myeloid leukemia- targeting the Guardians with novel approaches | SpringerLink
Cytokines increase engraftment of human acute myeloid leukemia cells in immunocompromised mice but not engraftment of human myelodysplastic syndrome cells | Haematologica
C-Type Lectin-Like Molecule-1 as a Biomarker for Diagnosis and Prognosis in Acute Myeloid Leukemia: A Preliminary Study
Example of a patient with an AML with minimal differentiation. The... | Download Scientific Diagram
Cancers | Free Full-Text | Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia
A robust xenotransplantation model for acute myeloid leukemia | Leukemia
Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia - ScienceDirect
Cancers | Free Full-Text | A Focus on Intermediate-Risk Acute Myeloid Leukemia: Sub-Classification Updates and Therapeutic Challenges
Acute Myelomonocytic Leukemia - an overview | ScienceDirect Topics
Extinguishing the Embers: Targeting AML Metabolism: Trends in Molecular Medicine
![보고서]급성 골수성 백혈병에서 골수유래억제세포의 역할 규명 및 종양 면역억제 기능의 조절을 통한 항암치료 성적 개선 방안](https://nrms.kisti.re.kr/bitextimages/TRKO201900021665/TRKO201900021665_7_image_1.png "보고서]급성 골수성 백혈병에서 골수유래억제세포의 역할 규명 및 종양 면역억제 기능의 조절을 통한 항암치료 성적 개선 방안")
보고서]급성 골수성 백혈병에서 골수유래억제세포의 역할 규명 및 종양 면역억제 기능의 조절을 통한 항암치료 성적 개선 방안
Anti-CD33 chimeric antigen receptor targeting of acute myeloid leukemia | Haematologica
Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option | Oncogene
